by M ABHIJNAN | Dec 23, 2023 | IPR
In the pharmaceutical industry, the practice of naming drugs after their active pharmaceutical ingredients (APIs) or the diseases they treat is a longstanding tradition. However, this practice has led to potential conflicts, prompting legal scrutiny. A recent case...
